We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

First Diagnostic Display Cleared for Viewing All Types of Breast Imaging

By MedImaging International staff writers
Posted on 04 Nov 2015
Print article
Coronis Uniti Multi-Modality Diagnostic Display
Coronis Uniti Multi-Modality Diagnostic Display (Photo courtesy of Barco)
A healthcare imaging specialist vendor has announce that one of the most prominent diagnostic displays it produces has been clinically validated for use for both Picture Archiving and Communication System (PACS) and multimodality breast imaging.

The US Food and Drug Administration (FDA; Silver Spring, MD USA) indicated the display for use in breast Magnetic Resonance Imaging (MRI), Computed Tomography (CT) and ultrasound, breast ultrasound, vascular and gynecological ultrasound on a single display, in grayscale, color, 2D or 3D, static or dynamic. The display had been previously cleared for viewing of mammography images, breast tomosynthesis, and PACS images.

The Coronis Uniti display was announced by Barco (Kortrijk, Belgium) and can used to access any image on a single workstation, saving time, and providing workflow and clinical benefits. The ability to run side-by-side comparisons and fuse images such as those from breast ultrasound and conventional mammography in women with dense breasts, has resulted in better detection of early breast cancer. The display can automatically set the correct color and grayscale settings for every image modality.
Coronis Uniti also enables radiologists to accurately visualize moving images in a 3D stack, ensuring efficient diagnosis, and a rapid workflow to prevent loss of detail while scrolling. Barco also found a way to counteract motion blur when reviewing image sequences.

Lynda Domogalla, Barco’s VP product marketing for Healthcare, said, “With Coronis Uniti, we wanted to break through the technical boundaries of multimodality integration and deliver the first unified workflow for radiologists in order to improve reading productivity as well health outcomes. We have succeeded in developing a ‘one size fits all’ diagnostic display—which defines a new bar for clinically-focused display solutions. To maximize the diagnostic value of color breast images, we developed new technologies to calibrate and maintain the consistency of these color images, and we are leading in the definition of a Color Standard Display Function (CSDF) to ensure the accuracy and consistency of color images on diagnostic displays.”

Related Links:

Barco


Portable Color Doppler Ultrasound Scanner
DCU10
New
Leg Wraps
Leg Wraps
Wall Fixtures
MRI SERIES
New
Cylindrical Water Scanning System
SunSCAN 3D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more